Keith R. Alexandra 4

What Happened
Keith R. Alexandra, a director of Thermo Fisher Scientific, was granted 60.91 deferred stock units on 2026-06-27 as an award under the company's director Deferred Compensation Plan. The filing lists a per-unit price of $513.03, which values the award at roughly $31,250. These are derivative units convertible 1-for-1 into common shares (see footnotes).

Key Details

• Transaction date: June 27, 2026; Form 4 filed June 30, 2026.
• Transaction type: Grant / Award (coded "A"); 60.91 deferred stock units at $513.03 per unit (~$31,250 total).
• Derivative treatment: Units are convertible into common stock on a 1-for-1 basis (Footnote F1).
• Plan specifics: Units represent director retainer deferrals under the Issuer's Deferred Compensation Plan for Directors; shares are distributable as stock upon cessation of director service or a change of control (Footnote F2).
• Shares owned after transaction: Not disclosed in the provided excerpt.
• Filing timeliness: Filing date is shown as June 30, 2026; the excerpt does not indicate a late-filing flag.

Context
This was a routine director compensation award (deferred stock units), not an open-market purchase or sale. Because the units are deferred and only convert to actual shares upon certain events (e.g., leaving the board or change of control), this transaction is primarily a compensation event rather than a clear buy/sell signal about the director's view of the stock.